Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference
05/23/2022 - 08:00 AM
WIXOM, Mich. , May 23, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that Russell Ellison , M.D., M.Sc., President and Chief Executive Officer is scheduled to present at H.C. Wainwright's Annual Global Life Sciences Conference in Miami, Florida on Tuesday, May 24 th at 3:30 PM ET .
A video webcast of the presentation will be available the following day in the "Investors" section of the Company's website at www.rockwellmed.com , and will be archived on the Company's website for 90 days.
About Rockwell Medical
Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients' lives. The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. Rockwell Medical is also advancing its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting. In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States . For more information, visit www.RockwellMed.com .
View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-medical-inc-to-present-at-hc-wainwright-annual-global-life-sciences-conference-301552591.html
SOURCE Rockwell Medical Technologies, Inc.
RMTI Rankings
#245 Ranked by Stock Gains
RMTI Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Wixom
About RMTI
rockwell medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (esrd) and chronic kidney disease (ckd) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. rockwell’s new innovative therapy triferic is the only fda approved drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia. via dialysate during each dialysis treatment, triferic replaces the 5-7 mg iron loss that occurs in all patients, maintaining their iron balance. unlike iv iron products, triferic binds iron immediately and completely to transferrin (carrier of iron in the body) upon entering the blood and is then transported directly to the bone marrow to be incorporated into hemoglobin, with no increase in ferritin (stored iron and inflammation) and no anaphylaxis, addressing a significant unmet need in overcoming functional iron deficiency (fid) in esrd patients. visit www